Loss of XXXX , @entity23422 , and @entity19689 Expression During Progression of @entity356 .

@entity70777 @entity23422 @entity19689 @entity10161 @entity5 @entity1129 @entity652 @entity356
BACKGROUND/AIM: @entity356 is a common @entity5 worldwide. Chromatin remodeling complexes have emerged as @entity5 suppressors and include @entity1129 ( @entity1129 ) 1A, 1B, and 2. We examined their expression and clarified their roles in @entity356 . MATERIALS AND METHODS: The expression of @entity1129 was studied by immunohistochemistry in 469 @entity356 and 47 @entity652 samples and was analyzed according to clinicopathological factors. RESULTS: Low expression rates of @entity70777 , and 2 in @entity356 were 20%, 10%, and 15% respectively. @entity1129 are correlated to each other. Low expression of @entity10161 was related to advanced @entity5 and vessel infiltration. Loss of @entity23422 and @entity19689 was also related to @entity5 progression, but their relationship was weaker than that of @entity10161 . CONCLUSION: @entity10161 is the strongest @entity5 suppressor in @entity356 among @entity1129 . Their aberration might be caused by shared mechanisms such as mutation and methylation.
